<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR72008</article-id>
      <title-group>
        <article-title>A Comprehensive Review on Novel Approaches In Cancer Treatment</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Doshi</surname>
            <given-names>Darshana V.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khadke</surname>
            <given-names>Anand P.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khadke</surname>
            <given-names>Anuradha A.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bhagwat</surname>
            <given-names>Avinash M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2017-04-01">
        <month>04</month>
        <day>01</day>
        <year>2017</year>
      </pub-date>
      <volume>7</volume>
      <issue>2</issue>
      <abstract>
        <p>Cancer drug development is leading the way in exploiting molecular biological and genetic information to develop ’personalized’ medicine. The therapies such as immunotherapy, gene targeted nucleic acid therapy, targeting angiogensis for treatment, chemotherapy are introduced for the treatment of cancer. In chemotherapy the drug new drug are introduced nivolumab, bevacizumab, belinostat, bilinatumomab.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>cancer treatment</kwd>
        <kwd>immunotherapy</kwd>
        <kwd>chemotherapy</kwd>
        <kwd>targeting angiogensis</kwd>
        <kwd>nucleic acid therapy.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
